Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

202 Views

H4. HIV: Treatment

Poster Session: HIV: Treatment

(P-359) Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir

Monday, October 20, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Jing Niu, MD, MS (she/her/hers)

Director of Clinical Pharmacology
Gilead Sciences, Inc., Foster City, CA, USA
Foster City, CA, United States

Co-Author(s)

HZ

Haeyoung Zhang, PharmD, PhD

Gilead Sciences Inc
Foster City, California, United States
JL

John Ling, n/a

Gilead Sciences, Inc., Foster City, CA, USA
Foster City, California, United States
SM

Sharline Madera, MD, PhD

Gilead Sciences, Inc.
Foster City, California, United States
NK

Nerissa Kwok, PharmD

Gilead Sciences, Inc., Foster City, CA, USA
Foster City, California, United States
SW

Steve West, MSPH

Gilead Sciences, Inc., Foster City, CA, USA
Foster City, California, United States
DL

Diane Longo, PhD

Merck & Co., Inc., Rahway, NJ, USA
Rahway, New Jersey, United States
GG

Gillian Gillespie, MB, Bchir

Merck & Co., Inc., Rahway, NJ, USA
Rahway, New Jersey, United States
CL

Cyril Llamoso, MD

Merck & Co., Inc., Rahway, NJ, USA
Rahway, New Jersey, United States
DM

Dhananjay Marathe, PhD

Gilead Sciences, Inc.
Foster City, California, United States